Skip to Content

Amturnide Approval History

  • FDA approved: Yes (First approved December 21st, 2010)
  • Brand name: Amturnide
  • Generic name: aliskiren, amlodipine and hydrochlorothiazide
  • Dosage form: Tablets
  • Company: Novartis Pharmaceuticals Corporation
  • Treatment for: High Blood Pressure

Amturnide (aliskiren, amlodipine and hydrochlorothiazide) is a direct renin inhibitor, calcium channel blocker and diuretic combination for the treatment of high blood pressure.

Development History and FDA Approval Process for Amturnide

Dec 22, 2010Approval Novartis Gains FDA Approval for Amturnide, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.